UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000003070
Receipt number R000003724
Scientific Title Efficacy of low dose budesonide inhalation suspension / sodium cromoglicate inhalation solution for mild / moderate persistent asthma in young children
Date of disclosure of the study information 2010/01/21
Last modified on 2011/04/08 14:09:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy of low dose budesonide inhalation suspension / sodium cromoglicate inhalation solution for mild / moderate persistent asthma in young children

Acronym

Efficacy of low dose budesonide inhalation for mild / moderate persistent asthma in young children (Mild One Study)

Scientific Title

Efficacy of low dose budesonide inhalation suspension / sodium cromoglicate inhalation solution for mild / moderate persistent asthma in young children

Scientific Title:Acronym

Efficacy of low dose budesonide inhalation for mild / moderate persistent asthma in young children (Mild One Study)

Region

Japan


Condition

Condition

bronchial asthma

Classification by specialty

Pneumology Clinical immunology Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate efficacy of budesonide inhalation suspension 0.25 mg qd (1 inh./day) administrate on 12 weeks for mild / moderate persistent bronchial asthma in young children.
Moreover to evaluate efficacy sodium cromoglicate inhalation solution (for nebulizer use), the standard for nonsteroidal therapy, on same terms as a reference.
To collect preliminary data for large scale clinical test.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Daytime and nighttime symptom score at baseline and after 12 weeks of administration (0-3 point scale).

Key secondary outcomes

- Score of symptom (based on asthma diary, 0-9 point scale)
- Frequency of use inhaled short acting beta2 agonist(SABA)
- Level of blood serum cortisol at baseline and end of study
- Level of blood serum ECP at baseline and end of study
- Unscheduled hospital visits and emergency room visit because of asthma exacerbation
- Adverse events


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking


Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

BIS administration group
Budesonide inhalation suspension 0.25 mg, once daily before bed for 12 weeks using jet nebulizer (PARI TurboBOY N, PARI LC Plus Nebulizer)

Interventions/Control_2

CIS administration group
Sodium cromoglicate inhalant solution 20 mg, 3 times daily (morning, afternoon (or evening), before bedtime) for 12 weeks using jet nebulizer (PARI TurboBOY N, PARI LC Plus Nebulizer)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

6 months-old <=

Age-upper limit

60 months-old >

Gender

Male and Female

Key inclusion criteria

Mild to moderate persistent asthma patients (JPGL 2005, Pediatr Int. 2007 Dec;49(6):1023-31)

Key exclusion criteria

1. Patients who have a case listed below within a month
a)Severe respiratory infection disease that required hospitalization
b)Administration of systemic steroid

2. Patients who have underlying disease that indicate chronic airway symptom exclude asthma

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Toshio Katsunuma

Organization

Jikei University School of Medicine

Division name

Department of Pediatrics

Zip code


Address

3-25-8, Nishi-Shinbashi, Minato-ku, Tokyo, Japan

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name Toshio Katsunuma

Organization

Jikei University School of Medicine

Division name

Department of Pediatrics

Zip code


Address

3-25-8, Nishi-Shinbashi, Minato-ku, Tokyo, Japan

TEL


Homepage URL


Email



Sponsor or person

Institute

Mild One research society

Institute

Department

Personal name



Funding Source

Organization

Japan Allergy Foundation

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京慈恵会医科大学(東京都)
町立津南病院(新潟県)
国立成育医療センター(東京都)
富山大学(富山県)
獨協医科大学(栃木県)
富山赤十字病院(富山県)
慈愛会今村病院(鹿児島県)
やのファミリークリニック(鹿児島県)
おのうえこどもクリニック(富山県)
糸魚川総合病院(新潟県)
吉原医院(栃木県)


Other administrative information

Date of disclosure of the study information

2010 Year 01 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2007 Year 05 Month 31 Day

Date of IRB


Anticipated trial start date

2008 Year 05 Month 01 Day

Last follow-up date

2010 Year 08 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2010 Year 01 Month 21 Day

Last modified on

2011 Year 04 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003724


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name